Enlivex Therapeutics (Israel) Buy Hold or Sell Recommendation
| ENLV Stock | ILA 452.60 1.80 0.40% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Enlivex Therapeutics is 'Strong Sell'. Macroaxis provides Enlivex Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ENLV positions.
Check out Enlivex Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide. In addition, we conduct extensive research on individual companies such as Enlivex and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Enlivex |
Execute Enlivex Therapeutics Buy or Sell Advice
The Enlivex recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Enlivex Therapeutics. Macroaxis does not own or have any residual interests in Enlivex Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Enlivex Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Enlivex Therapeutics Trading Alerts and Improvement Suggestions
| Enlivex Therapeutics generated a negative expected return over the last 90 days | |
| Enlivex Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (14.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Enlivex Therapeutics has accumulated about 90.6 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95. | |
| Roughly 12.0% of the company shares are held by company insiders |
Enlivex Therapeutics Returns Distribution Density
The distribution of Enlivex Therapeutics' historical returns is an attempt to chart the uncertainty of Enlivex Therapeutics' future price movements. The chart of the probability distribution of Enlivex Therapeutics daily returns describes the distribution of returns around its average expected value. We use Enlivex Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Enlivex Therapeutics returns is essential to provide solid investment advice for Enlivex Therapeutics.
| Mean Return | -0.02 | Value At Risk | -6.17 | Potential Upside | 7.07 | Standard Deviation | 4.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Enlivex Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Enlivex Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Enlivex Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Enlivex Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Enlivex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 4.78 | |
Ir | Information ratio | -0.03 |
Enlivex Therapeutics Volatility Alert
Enlivex Therapeutics exhibits very low volatility with skewness of 1.2 and kurtosis of 3.28. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Enlivex Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Enlivex Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Enlivex Therapeutics Fundamentals Vs Peers
Comparing Enlivex Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enlivex Therapeutics' direct or indirect competition across all of the common fundamentals between Enlivex Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enlivex Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Enlivex Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Enlivex Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enlivex Therapeutics to competition |
| Fundamentals | Enlivex Therapeutics | Peer Average |
| Return On Equity | -0.38 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Current Valuation | 147.66 M | 16.62 B |
| Shares Outstanding | 18.41 M | 571.82 M |
| Shares Owned By Insiders | 12.19 % | 10.09 % |
| Shares Owned By Institutions | 9.53 % | 39.21 % |
| Price To Book | 1.23 X | 9.51 X |
| EBITDA | (18.74 M) | 3.9 B |
| Net Income | (14.47 M) | 570.98 M |
| Cash And Equivalents | 90.6 M | 2.7 B |
| Cash Per Share | 4.95 X | 5.01 X |
| Total Debt | 615 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 20.29 X | 2.16 X |
| Book Value Per Share | 3.44 X | 1.93 K |
| Cash Flow From Operations | (17.54 M) | 971.22 M |
| Earnings Per Share | (1.07) X | 3.12 X |
| Number Of Employees | 71 | 18.84 K |
| Beta | 0.61 | -0.15 |
| Market Capitalization | 273.23 M | 19.03 B |
| Total Asset | 95.15 M | 29.47 B |
| Net Asset | 95.15 M |
Enlivex Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Enlivex . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Enlivex Therapeutics Buy or Sell Advice
When is the right time to buy or sell Enlivex Therapeutics? Buying financial instruments such as Enlivex Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Enlivex Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Risk ETFs Thematic Idea Now
Target Risk ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Enlivex Stock
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:Check out Enlivex Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.